Funding Alert: Contact Congress for Emergency Funding for Zika

Please contact Congress to urge the immediate passage of a bipartisan emergency supplemental bill for Zika.
Take Action

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
New Governance Information
Become a member today!
Submit Abstracts for ABRCMS
Register for ABRCMS
meng xiang-jin

Dr. Meng’s research focuses on molecular mechanisms of viral pathogenesis and vaccine developments against emerging and zoonotic viruses of veterinary and human public health significance. The viruses being studied in the Meng lab include hepatitis E viruses (human, swine, avian, and rabbit HEVs), porcine circovirus 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), and Torque teno sus virus (TTSuV). Dr. Meng is responsible for the discoveries of swine hepatitis E virus from pigs and avian hepatitis E virus from chickens in the United States. Dr. Meng has published more than 220 scientific papers, reviews and book chapters. According to Thompson Scientific’s ISI Essential Science Indicators, Dr. Meng is ranked in the top 1% highly-cited scientists in the field of Microbiology based on total citations from 1997 to 2007. Dr. Meng is an inventor for more than 20 patents on various virus vaccines and diagnostics. For example, Meng is the lead inventor of the first USDA fully-licensed commercial vaccine, Fostera™ PCV (formerly Suvaxyn® PCV2 One DoseTM), against PCV2. Currently, working with multiple virus systems (HEV, PRRSV, PCV2, and TTSuV), the Meng lab is dissecting the structural and functional relationship of viral genes and developing effective vaccines against these emerging and zoonotic viruses.

Dr. Meng’s Lab Website: http://www.tinyurl.com/mengxj